![Ambisome <br> Antifungal Amphotericin B Liposome <br>50 mg / 20 mL Intravenous Injection <br>Vial 20 mL <br> Astellas 00469305130 Ambisome <br> Antifungal Amphotericin B Liposome <br>50 mg / 20 mL Intravenous Injection <br>Vial 20 mL <br> Astellas 00469305130](https://s.turbifycdn.com/aah/yhst-12533177228474/ambisome-antifungal-amphotericin-b-liposome-50-mg-20-ml-intravenous-injection-vial-20-ml-astellas-00469305130-28.gif)
Ambisome <br> Antifungal Amphotericin B Liposome <br>50 mg / 20 mL Intravenous Injection <br>Vial 20 mL <br> Astellas 00469305130
![Aerosolized liposomal amphotericin B: Prediction of lung deposition, in vitro uptake and cytotoxicity - ScienceDirect Aerosolized liposomal amphotericin B: Prediction of lung deposition, in vitro uptake and cytotoxicity - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0378517312006874-fx1.jpg)
Aerosolized liposomal amphotericin B: Prediction of lung deposition, in vitro uptake and cytotoxicity - ScienceDirect
![Pharmaceutics | Free Full-Text | Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy Pharmaceutics | Free Full-Text | Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy](https://www.mdpi.com/pharmaceutics/pharmaceutics-12-00029/article_deploy/html/images/pharmaceutics-12-00029-g001.png)
Pharmaceutics | Free Full-Text | Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy
![Figure 2 from Bioactivity, Safety, and Efficacy of Amphotericin B Nanomicellar Aerosols Using Sodium Deoxycholate Sulfate as the Lipid Carrier | Semantic Scholar Figure 2 from Bioactivity, Safety, and Efficacy of Amphotericin B Nanomicellar Aerosols Using Sodium Deoxycholate Sulfate as the Lipid Carrier | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1aec95f715152511e3dd014428fe4ef763a130a0/3-Figure2-1.png)
Figure 2 from Bioactivity, Safety, and Efficacy of Amphotericin B Nanomicellar Aerosols Using Sodium Deoxycholate Sulfate as the Lipid Carrier | Semantic Scholar
![The efficacy of aerosol treatment with non-ionic surfactant vesicles containing amphotericin B in rodent models of leishmaniasis and pulmonary aspergillosis infection - ScienceDirect The efficacy of aerosol treatment with non-ionic surfactant vesicles containing amphotericin B in rodent models of leishmaniasis and pulmonary aspergillosis infection - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0168365912002453-fx1.jpg)
The efficacy of aerosol treatment with non-ionic surfactant vesicles containing amphotericin B in rodent models of leishmaniasis and pulmonary aspergillosis infection - ScienceDirect
![Aerosolized AmBisome Treatment of Pulmonary Cryptococcus neoformans Infection in Mice | Journal of Aerosol Medicine Aerosolized AmBisome Treatment of Pulmonary Cryptococcus neoformans Infection in Mice | Journal of Aerosol Medicine](https://www.liebertpub.com/cms/10.1089/jam.1996.9.issue-2/asset/1511bb22-b815-1bb2-6b81-11bb226b8151/cover.jpg)
Aerosolized AmBisome Treatment of Pulmonary Cryptococcus neoformans Infection in Mice | Journal of Aerosol Medicine
![Notice patient - AMBISOME liposomal 50 mg, poudre pour dispersion pour perfusion - Base de données publique des médicaments Notice patient - AMBISOME liposomal 50 mg, poudre pour dispersion pour perfusion - Base de données publique des médicaments](https://base-donnees-publique.medicaments.gouv.fr/Rcp_Notices/images//N0348207/image011.jpg)
Notice patient - AMBISOME liposomal 50 mg, poudre pour dispersion pour perfusion - Base de données publique des médicaments
![Pharmaceutics | Free Full-Text | Could the Lung Be a Gateway for Amphotericin B to Attack the Army of Fungi? Pharmaceutics | Free Full-Text | Could the Lung Be a Gateway for Amphotericin B to Attack the Army of Fungi?](https://www.mdpi.com/pharmaceutics/pharmaceutics-14-02707/article_deploy/html/images/pharmaceutics-14-02707-g001.png)
Pharmaceutics | Free Full-Text | Could the Lung Be a Gateway for Amphotericin B to Attack the Army of Fungi?
![Prophylactic efficacy of single dose pulmonary administration of amphotericin B inhalation powder in a guinea pig model of invasive pulmonary aspergillosis. | Semantic Scholar Prophylactic efficacy of single dose pulmonary administration of amphotericin B inhalation powder in a guinea pig model of invasive pulmonary aspergillosis. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2f58fcd55d31f38f321a29aaa0e6bac3426d2eb1/2-Figure1-1.png)
Prophylactic efficacy of single dose pulmonary administration of amphotericin B inhalation powder in a guinea pig model of invasive pulmonary aspergillosis. | Semantic Scholar
Aerosolization of Liposomal Amphotericin B (AmBisome®) Maintains Antifungal Drug Concentrations in Lungs for up to Five Days Po
![Aerosolized liposomal Amphotericin B: A potential prophylaxis of invasive pulmonary aspergillosis in immunocompromised patients - Kamalaporn - 2014 - Pediatric Pulmonology - Wiley Online Library Aerosolized liposomal Amphotericin B: A potential prophylaxis of invasive pulmonary aspergillosis in immunocompromised patients - Kamalaporn - 2014 - Pediatric Pulmonology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/7c30eadc-3ab6-494e-94d6-8159876aec95/ppul22856-fig-0002-m.jpg)
Aerosolized liposomal Amphotericin B: A potential prophylaxis of invasive pulmonary aspergillosis in immunocompromised patients - Kamalaporn - 2014 - Pediatric Pulmonology - Wiley Online Library
![Notice patient - AMBISOME liposomal 50 mg, poudre pour dispersion pour perfusion - Base de données publique des médicaments Notice patient - AMBISOME liposomal 50 mg, poudre pour dispersion pour perfusion - Base de données publique des médicaments](https://base-donnees-publique.medicaments.gouv.fr/Rcp_Notices/images//N0348207/image009.jpg)
Notice patient - AMBISOME liposomal 50 mg, poudre pour dispersion pour perfusion - Base de données publique des médicaments
![Liposomal Amphotericin B (AmBisome®): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions | Drugs Liposomal Amphotericin B (AmBisome®): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions | Drugs](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40265-016-0538-7/MediaObjects/40265_2016_538_Fig1_HTML.gif)
Liposomal Amphotericin B (AmBisome®): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions | Drugs
![Nebulizer Choice Affects the Airway Targeting of Amphotericin B Lipid Complex Aerosols - Maria Polikandritou Lambros, Paul M. Beringer, Annie Wong-Beringer, 2013 Nebulizer Choice Affects the Airway Targeting of Amphotericin B Lipid Complex Aerosols - Maria Polikandritou Lambros, Paul M. Beringer, Annie Wong-Beringer, 2013](https://journals.sagepub.com/cms/10.1177/8755122513500905/asset/images/large/10.1177_8755122513500905-fig1.jpeg)